Enabling Pharma Compliance with IVDR for Precision Medicine Trials

5:50 pm - Tuesday 31st March 2026

  • How can pharma build IVDR capabilities to effectively deliver precision medicine trials in the EU?
  • How to achieve IVDR compliance for trials with or without diagnostic company involvement?
  • How to enable smooth collaboration between pharma, IVD manufacturer and/or CRO(s) for National Competent Authority submissions and approvals?

Speakers:

Senior Director, Global Precision Medicine Lead
Astellas Pharma